Clinical trial · Interventional
WEST-KOaST Study: WES Analysis of Testicular Cancer Patientsand Their First-degree Family Members
WEST-KOaST Study: WES (Whole Exome Sequencing) Analysis of Testicular Cancer Patientsand Their First-degree Family Members
NCT06142500CI-TRIAL-00071562West-KOaStnot yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The project aims to identify the possible risk factors regarding the onset of the disease and to evaluate genes and gene modifications responsible for the onset od testicular cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Testicular Cancer | Malignant Testicular Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Patients with testicular cancer
- description
- Patient with testicular cancer
- interventionNames
- Genetic: Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members
- type
- ACTIVE_COMPARATOR
- label
- First-degree family members of patients with testicular cancer
- description
- First-degree family members of patients with testicular cancer
- interventionNames
- Genetic: Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members
Primary outcomes (1)
- measure
- Saliva biological sample
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Male testicular cancer patients with an age \> 18 and \< 90 * First degree family members of Male testicular cancer patients with an age \> 18 and \< 90 * Ability to read and sign the informed consent * Diagnosis of testicular cancer for the experimental group Exclusion Criteria: * Female for the experimental group * Second degree family members of Male testicular cancer patients * People with an age \< 18 and \> 90 * Diagnosis different from testicular cancer for the experimental group Incapacity to read and sign the informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.